Fructooligosaccharides and galactooligosaccharides improve hepatic steatosis via gut microbiota-brain axis modulation

References

• Ahmadi S, Nagpal R, Wang S, Gagliano J, Kitzman DW, Soleimanian-Zad S, Sheikh-Zeinoddin M, Read R, Yadav H. 2019. Prebiotics from acorn and sago prevent high-fat-diet-induced insulin resistance via microbiome–gut–brain axis modulation. J Nutr Biochem. 67:1–13. doi:10.1016/j.jnutbio.2019.01.011.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WPT, Loria CM, Smith SC. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644.
   PubMed Web of Science ®Google Scholar
• Albuquerque‐Souza E, Sahingur SE. 2022. Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis. Periodontology. 89(1):125–141. doi:10.1111/prd.12427.
   Google Scholar
• Altamirano-Barrera A, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. 2018. The role of the gut microbiota in the pathology and prevention of liver disease. J Nutr Biochem. 60:1–8. doi:10.1016/j.jnutbio.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Behrouz V, Aryaeian N, Zahedi MJ, Jazayeri S. 2020. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: a randomized clinical trial. J Food Sci. 85(10):3611–3617. doi:10.1111/1750-3841.15367.
   PubMed Web of Science ®Google Scholar
• Beisner J, Filipe Rosa L, Kaden-Volynets V, Stolzer I, Günther C, Bischoff SC. 2021. Prebiotic inulin and sodium butyrate attenuate obesity-induced intestinal barrier dysfunction by induction of antimicrobial peptides. Front Immunol. 12(June):678360. doi:10.3389/fimmu.2021.678360.
   PubMedGoogle Scholar
• Bindels LB, Dewulf EM, Delzenne NM. 2013. GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends Pharmacol Sci. 34(4):226–232. doi:10.1016/j.tips.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Bliesner A, Eccles-Smith J, Bates C, Hayes O, Ho JY, Martins C, Truby H, Nitert MD. 2022. Impact of food-based weight loss interventions on gut microbiome in individuals with obesity: a systematic review. Nutrients. 14(9):1953. doi:10.3390/nu14091953.
   PubMed Web of Science ®Google Scholar
• Boden G. 2011. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 18(2):139–143. doi:10.1097/MED.0b013e3283444b09.
   PubMed Web of Science ®Google Scholar
• Bomhof MR, Parnell JA, Ramay HR, Crotty P, Rioux KP, Probert CS, Jayakumar S, Raman M, Reimer RA. 2019. Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial. Eur J Nutr. 58(4):1735–1745. doi:10.1007/s00394-018-1721-2.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, et al. 2003. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem. 278(13):11312–11319. doi:10.1074/jbc.M211609200.
   PubMed Web of Science ®Google Scholar
• Burokas A, Arboleya S, Moloney RD, Peterson VL, Murphy K, Clarke G, Stanton C, Dinan TG, Cryan JF. 2017. Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiatry. 82(7):472–487. doi:10.1016/j.biopsych.2016.12.031.
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Maton N, Delzenne NM. 2005. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like peptide. Obes Res. 13(6):1000–1007. doi:10.1038/oby.2005.117.
   PubMedGoogle Scholar
• Camilleri M. 2019. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 68(8):1516–1526. doi:10.1136/gutjnl-2019-318427.
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. 2007. Resistance. Diabetes. 56(7):1761–1772. doi:10.2337/db06-1491.P.D.C.
   PubMed Web of Science ®Google Scholar
• Cani PD, Hoste S, Guiot Y, Delzenne NM. 2007. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr. 98(1):32–37. doi:10.1017/S0007114507691648.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, et al. 2012. Ultra-high-throughput microbial community analysis on the illumina HiSeq and MiSeq platforms. Isme J. 6(8):1621–1624. doi:10.1038/ismej.2012.8.
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 67(1):328–357. doi:10.1002/hep.29367.
   PubMed Web of Science ®Google Scholar
• Chappuis E, Morel-Depeisse F, Bariohay B, Roux J. 2017. Alpha-galacto-oligosaccharides at low dose improve liver steatosis in a high-fat diet mouse model. Molecules. 22(10):1725. doi:10.3390/molecules22101725.
   PubMed Web of Science ®Google Scholar
• Christoff AP, A, Fernanda R, Sereia Dellyana R, Boberg R, Lucio VD, Moraes, LFVD, Oliveira. 2017. Sequencing neoprospecta microbiome technologies bacterial identification through accurate library preparation and high-throughput sequencing. White Paper: Bacterial NGS, no. May 2017. http://neoprospecta.com.
   Google Scholar
• Chunchai T, Thunapong W, Yasom S, Wanchai K, Eaimworawuthikul S, Metzler G, Lungkaphin A, Pongchaidecha A, Sirilun S, Chaiyasut C, et al. 2018. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats. J Neuroinflammation. 15(1):11. doi:10.1186/s12974-018-1055-2.
   PubMed Web of Science ®Google Scholar
• Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. 2019. The role of short-chain fatty acids in microbiota–gut–brain communication. Nat Rev Gastroenterol Hepatol. 16(8):461–478. doi:10.1038/s41575-019-0157-3.
   PubMed Web of Science ®Google Scholar
• De La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 299(2):G440–448. doi:10.1152/ajpgi.00098.2010.
   PubMed Web of Science ®Google Scholar
• Delmée E, Cani PD, Gual G, Knauf C, Burcelin R, Maton N, Delzenne NM. 2006. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice. Life Sci. 79(10):1007–1013. doi:10.1016/j.lfs.2006.05.013.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Fordjour L, Ahmad A, Cai C, Kumar D, Valencia G, Aranda JV, Beharry KD. 2010. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res. 67(5):526–531. doi:10.1203/PDR.0b013e3181d4ff2b.
   PubMed Web of Science ®Google Scholar
• Duan Y, Zeng L, Zheng C, Song B, Li F, Kong X, Xu K. 2018. Inflammatory links between high fat diets and diseases. Front Immunol. 9(NOV):2649. doi:10.3389/fimmu.2018.02649.
   PubMedGoogle Scholar
• Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 60(11):2775–2786. doi:10.2337/db11-0227.
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. 2021. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 19(1):55–71. doi:10.1038/s41579-020-0433-9.
   PubMed Web of Science ®Google Scholar
• Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, Brody L, Anastasovska J, Ghourab S, Hankir M, Zhang S, et al. 2014. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 5(1):3611. : doi:10.1038/ncomms4611.
   PubMed Web of Science ®Google Scholar
• Gastaldelli A, Gaggini M, DeFronzo RA. 2017. Role of adipose tissue insulin resistance in the natural history of type 2 diabetes: results from the San Antonio metabolism study. Diabetes. 66(4):815–822. doi:10.2337/db16-1167.
   PubMed Web of Science ®Google Scholar
• Gupta H, Min B-H, Ganesan R, Gebru YA, Sharma SP, Park E, Won S-M, Jeong J-J, Lee S-B, Cha M-G, et al. 2022. Gut microbiome in non-alcoholic fatty liver disease: from mechanisms to therapeutic role. Biomedicines. 10(3):550. doi:10.3390/biomedicines10030550.
   PubMed Web of Science ®Google Scholar
• Gupta H, Soo Youn G, Shin MJ, Suk KT. 2019. Role of gut microbiota in hepatocarcinogenesis. Microorganisms. 7(5):121. doi:10.3390/microorganisms7050121.
   PubMed Web of Science ®Google Scholar
• Huang X, Chen Q, Fan Y, Yang R, Gong G, Yan C, Song Y, Zhang B, Xi S, Huang Y, et al. 2023. Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism. Biomed Pharmacother. 159:114300. doi:10.1016/j.biopha.2023.114300.
   PubMed Web of Science ®Google Scholar
• Kim KA, Gu W, Lee IA, Joh EH, Kim DH. 2012. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS ONE. 7(10):e47713. doi:10.1371/journal.pone.0047713.
   PubMed Web of Science ®Google Scholar
• Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC. 2008. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 47(4):1363–1370. doi:10.1002/hep.22109.
   PubMed Web of Science ®Google Scholar
• Lecomte V, Kaakoush NO, Maloney CA, Raipuria M, Huinao KD, Mitchell HM, Morris MJ. 2015. Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS ONE. 10(5):e0126931. doi:10.1371/journal.pone.0126931.
   PubMed Web of Science ®Google Scholar
• Leung C, Rivera L, Furness JB, Angus PW. 2016. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 13(7):412–425. doi:10.1038/nrgastro.2016.85.
   PubMed Web of Science ®Google Scholar
• Ley K. 2021. Inflammation and atherosclerosis. Cells. 10(5):1197. doi:10.3390/cells10051197.
   PubMed Web of Science ®Google Scholar
• Li Y, Zong Y, Qi J, Liu K. 2011. Prebiotics and oxidative stress in constipated rats. J Pediatr Gastroenterol Nutr. 53(4):447–452. doi:10.1097/MPG.0b013e31821eed83.
   PubMed Web of Science ®Google Scholar
• Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, Ma Z, Bruno MJ, de Knegt RJ, Cao W, et al. 2022. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 20(3):e573–e582. doi:10.1016/j.cgh.2021.02.030.
   PubMed Web of Science ®Google Scholar
• Loman BR, Hernández-Saavedra D, An R, Scott Rector R. 2018. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutr Rev. 76(11):822–839. doi:10.1093/nutrit/nuy031.
   PubMed Web of Science ®Google Scholar
• Lotta LA, Gulati P, Day FR, Payne F, Ongen H, van de Bunt M, Gaulton KJ, Eicher JD, Sharp SJ, Luan J, et al. 2017. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat Genet. 49(1):17–26. doi:10.1038/ng.3714.
   PubMed Web of Science ®Google Scholar
• Ludgero-Correia A, Aguila MB, Mandarim-de-Lacerda CA, Faria TS. 2012. Effects of high-fat diet on plasma lipids, adiposity, and inflammatory markers in ovariectomized C57BL/6 mice. Nutrition. 28(3):316–323. doi:10.1016/j.nut.2011.07.014.
   PubMed Web of Science ®Google Scholar
• Lustig RH, Collier D, Kassotis C, Roepke TA, Kim MJ, Blanc E, Barouki R, Bansal A, Cave MC, Chatterjee S, et al. 2022. Obesity I: overview and molecular and biochemical mechanisms. Biochem Pharmacol. 199(March):115012. doi:10.1016/j.bcp.2022.115012.
   PubMedGoogle Scholar
• MacSween RN, Burt AD. 1986. Histologic spectrum of alcoholic liver disease. Semin Liver Dis. 6(3):221–232. doi:10.1055/s-2008-1040605.
   PubMed Web of Science ®Google Scholar
• Matata BM, Galiñanes M. 2002. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-ΚB DNA binding activity. J Biol Chem. 277(3):2330–2335. doi:10.1074/jbc.M106393200.
   PubMed Web of Science ®Google Scholar
• Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, Mcgilvray ID, Allard JP. 2013. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 58(1):120–127. doi:10.1002/hep.26319.
   PubMed Web of Science ®Google Scholar
• Nadeau BA, Conjeevaram H. 2017. The gut microbiome and nonalcoholic fatty liver disease. Clin Liver Dis (Hoboken). 10(5):116–119. doi:10.1002/cld.671.
   PubMedGoogle Scholar
• Obadia N, Andrade G, Leardini-Tristão M, Albuquerque L, Garcia C, Lima F, Daleprane J, Castro-Faria-Neto HC, Tibiriçá E, Estato V. 2022. TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice. J Neuroinflammation. 19(1):104. doi:10.1186/s12974-022-02465-3.
   PubMed Web of Science ®Google Scholar
• Paone P, Suriano F, Jian C, Korpela K, Delzenne NM, Van Hul M, Salonen A, Cani PD. 2022. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion. Gut Microbes. 14(1):2152307. Taylor and Francis Ltd. doi:10.1080/19490976.2022.2152307.
   PubMed Web of Science ®Google Scholar
• Perfield JW, Ortinau LC, Pickering RT, Ruebel ML, Meers GM, Rector RS. 2013. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. J Obes. 2013:296537–296538. doi:10.1155/2013/296537.
   PubMedGoogle Scholar
• Rashid H, Zulfia H, Ishtiaq SM, Ur Rasheed M, Naeem Faisal M, Aslam B, Muhammad F, Babar W, Abbas RZ, Khan JA. 2020. Prebiotics supplementation ameliorates high fat high sugar diet-associated oxidative stress. Pak Vet J. 40(04):467–473. doi:10.29261/pakvetj/2020.062.
   Google Scholar
• Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, et al. 2023. A multi-society Delphi consensus statement on new fatty liver disease nomenclature authors. J Hepatol. doi:10.1016/j.jhep.2023.06.003.
   Google Scholar
• Shahzad T, Iqbal S, Nasir M, Anjum AA, Imran M, Saeed F, Mahomoodally MF, Mehmood T, Zengin G, Mushtaq Z, et al. 2022. Comparative analysis of preventive role of different probiotics and prebiotics against the markers of liver damage, oxidative stress markers and inflammatory markers in the non-alcoholic fatty liver disease induced rats. Int J Food Prop. 25(1):2514–2529. Taylor & Francis: doi:10.1080/10942912.2022.2144881.
   Web of Science ®Google Scholar
• Song Q, Zhang X. 2022. The role of gut–liver axis in gut microbiome dysbiosis associated NAFLD and NAFLD-HCC. Biomedicines. 10(3):524. doi:10.3390/biomedicines10030524.
   PubMed Web of Science ®Google Scholar
• Stolfi C, Maresca C, Monteleone G, Laudisi F. 2022. Implication of intestinal barrier dysfunction in gut dysbiosis and diseases. Biomedicines. 10(2):289. doi:10.3390/biomedicines10020289.
   PubMed Web of Science ®Google Scholar
• Su Z. 2022. GOS ameliorates nonalcoholic fatty liver disease induced by high fat and high sugar diet through lipid metabolism and intestinal microbes. Nutrients. 14(13):2749.
   PubMed Web of Science ®Google Scholar
• Takai A, Kikuchi K, Ichimura M, Tsuneyama K, Moritoki Y, Matsumoto K, Tsunashima H, Onda T, Kuniyoshi N, Nariyama T, et al. 2020. Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol. 20(1):46. BMC Gastroenterology: doi:10.1186/s12876-020-01194-2.
   PubMed Web of Science ®Google Scholar
• Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 141(5):769–776. doi:10.3945/jn.110.135657.
   PubMed Web of Science ®Google Scholar
• Velázquez KT, Enos RT, Bader JE, Sougiannis AT, Carson MS, Chatzistamou I, Carson JA, Nagarkatti PS, Nagarkatti M, Murphy EA. 2019. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World J Hepatol. 11(8):619–637. doi:10.4254/wjh.v11.i8.619.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang Q, Yang C, Guo M, Cui X, Jing Z, Liu Y, Qiao W, Qi H, Zhang H, et al. 2022. Bacteroides acidifaciens in the gut plays a protective role against CD95-mediated liver injury. Gut Microbes. 14(1):2027853. doi:10.1080/19490976.2022.2027853.
   PubMed Web of Science ®Google Scholar
• Wang Y, Qian PY. 2009. Conservative fragments in bacterial 16S RRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies. PLoS ONE. 4(10):e7401. doi:10.1371/journal.pone.0007401.
   PubMed Web of Science ®Google Scholar
• Xie C, Halegoua-Demarzio D. 2019. Role of probiotics in non-alcoholic fatty liver disease: does gut microbiota matter? Nutrients. 11(11):2837. doi:10.3390/nu11112837.
   PubMed Web of Science ®Google Scholar
• Yang J-Y, Lee Y-S, Kim Y, Lee S-H, Ryu S, Fukuda S, Hase K, Yang C-S, Lim HS, Kim M-S, et al. 2017. Gut commensal bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol. 10(1):104–116. doi:10.1038/mi.2016.42.
   PubMed Web of Science ®Google Scholar
• Yao F, Jia R, Huang H, Yu Y, Mei L, Bai L, Ding Y, Zheng P. 2019. Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease. Arch Med Sci. 15(5):1336–1344. doi:10.5114/aoms.2019.86611.
   PubMed Web of Science ®Google Scholar
• Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 277(52):50230–50236. doi:10.1074/jbc.M200958200.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, et al. 2018. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 359(6380):1151–1156. doi:10.1126/science.aao5774.
   PubMed Web of Science ®Google Scholar